Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
Real-time insight on key fixed income and fx markets.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- MNI ResearchMNI Research
Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.
- About Us
Sign up now for free access to this content.
Please enter your details below and select your areas of interest.
Latest tracker polling from YouGov shows that a month after the widespread coverage of an extremely rare blood clotting issue in relation to the AstraZeneca COVID-19 vaccine, trust for the jab in Germany and France remains low. In Denmark trust has also collapsed following the gov'ts permanent halt to the vaccine's rollout there.
- AstraZeneca: UK: 78% safe (+1 from mid-Mar), Spain: 54% (+16), Italy: 48% (+12), Sweden: 44% (+1), Germany: 34% (+2), Denmark: 25% (-17), France: 22% (-1). Fieldwork 13-22 Apr.
Public trust in Europe is uniformly higher for those vaccines that have been rolled out most in each respective country, with the Pfizer/BioNTech and Moderna vaccines scoring well in highly-vaccinated states such as Denmark, Italy and Spain:
- Pfizer/BioNTech: Denmark: 81% safe (+5 from mid-Mar), UK: 80% safe (+1 from mid-Mar), Spain: 77% (+3), Italy: 76% (+7), Sweden: 70% (+9), Germany: 69% (+3), France: 56% (+5). Fieldwork 13-22 Apr.
- Moderna: Spain: 72% safe (+4 from mid-Mar), Denmark: 68% (+4), Italy: 66% (+10), Sweden: 63% (+7), UK: 63% safe (+13), Germany: 57% (+2), France: 47% (+8). Fieldwork 13-22 Apr.
There is also uniformly low trust in the Russian Sputnik V vaccine, although it is somewhat higher in Italy, Spain and Germany, where their gov'ts have spoken about securing doses outside the EU's purchase scheme if/when it is approved by the EMA:
- Sputnik V: Italy: 41% safe, Spain: 41%, Germany: 30%, Sweden: 23%, UK: 19%, France: 17%, Denmark: 12%. Fieldwork 13-22 Apr.